Review focuses biotech on portfolio potential

  • BiotechCo is a research-based pharmaceutical company that develops and commercializes drugs in several therapeutic areas 
  • BiotechCo has several products on the market and about a dozen in different stages of development 
  • The company has significant revenue from royalties and marketed products, with breakeven profitability 
  • BiotechCo's drug portfolio is increasingly complex and difficult to manage 
  • Public pressure is being applied by investors calling for strategic moves to jolt the stock out of its current range

Next Approach

Combine strategic priorities with project and process evaluation:

img

Next Recommendations

Review the highest-priority opportunities for strategic fit:


img

Next Results

Refocus resources on highest potential projects:


img
Related consulting services
Related industries